“anemia” Archives

Entry Author Date Location
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase 09/08/15 Boston
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More 06/26/14 San Francisco
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
San Diego Life Sciences Roundup: Arena, Organovo, Isis, & More 06/13/13 San Diego
Rockwell Medical Set to Disrupt Dialysis Treatment With New Drugs, DaVita Deal 05/09/13 Detroit Ann Arbor
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly 01/25/12 San Francisco
Acceleron Adds $30M From Partner Celgene and Existing Investors 12/23/11 Boston
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug 12/07/11 San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug 12/05/11 San Francisco
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny 11/17/11 San Francisco
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market 08/05/11 Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene 08/03/11 Boston
FDA Says It Will Review Affymax Drug 07/27/11 San Francisco
Affymax Raises $50M 03/18/11 San Francisco
Page 1 of 2 next page »